Request Demo
Last update 08 May 2026
D2M Biotherapeutics (Suzhou) Ltd.
Private Company|2022|Jiangsu Sheng, China
Private Company|2022|Jiangsu Sheng, China
Last update 08 May 2026
Overview
Basic Info
Introduction D2M Biotherapeutics (Suzhou) Ltd., established in the year 2020, was co-founded by the former Senior Director of Human Genetics Target Sciences at Pfizer Dr. Nan Bing, in collaboration with Dr. Dong Zhang, who previously served as the Director of Oncology Immunology at Merck Germany. D2M Biosciences aims to leverage its proprietary genomic data analysis platform to identify highly reliable novel targets and to engineer high-quality therapeutic molecules. By achieving continuous innovation at the source, the company strives to increase the rate of clinical success and bring safer and more effective treatment options to patients expeditiously. |
Tags
Immune System Diseases
Neoplasms
Skin and Musculoskeletal Diseases
Antibody
Bispecific antibody
Antibody drug conjugate (ADC)
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 14 Aug 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
6
1
Phase 1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free